Effect of delays in initiation of adjuvant endocrine therapy on survival among women with breast cancer
ConclusionThis study suggests that there may be no adverse impact on survival if initiation of AET occurs 12 to 24 months after initial diagnosis compared to within 12 months of diagnosis as currently recommended.
Source: Breast Cancer Research and Treatment - Category: Cancer & Oncology Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Databases & Libraries | Endocrine Therapy | Hormones | Insurance | Medicaid | Medicare | Statistics | Study | Women